JD Health's 2024 revenue rose 8.6% to RMB58.2B, with net profit up 94% to RMB4.2B, driven by omnichannel expansion, digital health, and AI initiatives. The company maintained strong cash reserves and no debt, with a positive outlook for continued growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.